Author

Eva Kassi

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Targeting Stress and the Gut–Brain Axis: Effects of Lifestyle and Psychobiotic Interventions on the Gut Microbiome in Adults—A Systematic Review of Randomized Controlled Trials

Background/Objectives: Stress is increasingly recognized as an important modulator of gut microbiome composition and function through the bidirectional microbiota–gut–brain axis. Dietary, psychobiotic, and other lifestyle-oriented interventions have therefore attracted growing interest as potential strategies for simul...

S. Asimakopoulou, Panagiotis Pipelias, Eva Kassi et al. · Nutrients · 0 citations

Review Open access Aug 2026

Safety and Efficacy of Mesenchymal Stem Cell Therapy in Aging Frailty: A Systematic Review

Aging frailty is a multifactorial geriatric syndrome characterized by reduced physiological reserve across multiple interrelated systems, leading to increased vulnerability to adverse health outcomes. Mesenchymal stem cells (MSCs) have emerged as a potential therapeutic intervention due to their immunomodulatory and re...

Eleni Poutouri, Maria Sotiropoulou, M. Potoupnis et al. · International Journal of Mol... · 0 citations

Open access Aug 2026

Empagliflozin inhibits the apoptosis of pancreatic β-cells through amelioration of endoplasmic reticulum (ER) stress

Background Progressive loss of pancreatic β-cell function in type 2 diabetes mellitus (T2DM) is linked to endoplasmic reticulum (ER) stress–induced apoptosis. Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) have glucose-lowering and potential cytoprotective effects. We investigated whether empagliflozin protects β-...

N. Nasiri-Ansari, Manpal S. Randeva, Christina-Maria Flessa et al. · Metabolism Open · 0 citations